Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Liane B. Russell August 27, 1923 - July 20, 2019.

Lieberman HB, Kimler BF.

Radiat Res. 2019 Aug;192(4):456-457. doi: 10.1667/RR0LBR.1. Epub 2019 Sep 6. No abstract available.

PMID:
31490739
2.

Differential sensitivity of inbred mouse strains to ovarian damage in response to low dose total body irradiation.

Quan N, Harris LR, Halder R, Trinidad CV, Johnson BW, Horton S, Kimler BF, Pritchard MT, Duncan FE.

Biol Reprod. 2019 Aug 22. pii: ioz164. doi: 10.1093/biolre/ioz164. [Epub ahead of print]

PMID:
31436294
3.

Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.

Fabian CJ, Nye L, Powers KR, Nydegger JL, Kreutzjans AL, Phillips TA, Metheny T, Winblad O, Zalles CM, Hagan CR, Goodman ML, Gajewski BJ, Koestler DC, Chalise P, Kimler BF.

Cancer Prev Res (Phila). 2019 Oct;12(10):711-720. doi: 10.1158/1940-6207.CAPR-19-0315. Epub 2019 Aug 16.

PMID:
31420361
4.

Circulating adipose stromal cells as a response biomarker in phase II energy balance trials of obese breast cancer survivors and high-risk women.

Baker HA, Fabian CJ, Hastings RC, Dixon DA, Nydegger JL, Phillips TA, Powers KR, Kimler BF.

Breast Cancer Res Treat. 2019 Jul;176(2):387-394. doi: 10.1007/s10549-019-05251-7. Epub 2019 Apr 30.

PMID:
31041685
5.

Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.

Nag D, Bhanja P, Riha R, Sanchez-Guerrero G, Kimler BF, Tsue TT, Lominska C, Saha S.

Clin Cancer Res. 2019 Aug 1;25(15):4791-4807. doi: 10.1158/1078-0432.CCR-18-2751. Epub 2019 Apr 2.

PMID:
30940656
6.
7.

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.

Sharma P, López-Tarruella S, García-Saenz JA, Khan QJ, Gómez HL, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell AC, Monte-Millán MD, González-Rivera M, Massarrah T, Pelaez-Lorenzo B, Palomero MI, González Del Val R, Cortés J, Fuentes-Rivera H, Morales DB, Márquez-Rodas I, Perou CM, Lehn C, Wang YY, Klemp JR, Mammen JV, Wagner JL, Amin AL, O'Dea AP, Heldstab J, Jensen RA, Kimler BF, Godwin AK, Martín M.

Clin Cancer Res. 2018 Dec 1;24(23):5820-5829. doi: 10.1158/1078-0432.CCR-18-0585. Epub 2018 Jul 30.

PMID:
30061361
8.

Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells.

Tawfik O, Kimler BF, Karnik T, Shehata P.

Hum Pathol. 2018 Oct;80:170-178. doi: 10.1016/j.humpath.2018.06.008. Epub 2018 Jun 22.

PMID:
29936058
9.

Gender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?

Rider V, Abdou NI, Kimler BF, Lu N, Brown S, Fridley BL.

Front Immunol. 2018 Mar 28;9:611. doi: 10.3389/fimmu.2018.00611. eCollection 2018.

10.

Radiation-induced ovarian follicle loss occurs without overt stromal changes.

Kimler BF, Briley SM, Johnson BW, Armstrong AG, Jasti S, Duncan FE.

Reproduction. 2018 Jun;155(6):553-562. doi: 10.1530/REP-18-0089. Epub 2018 Apr 10.

11.

The Conundrum of Omega-3 Fatty Acids in Cancer Prevention Studies: Which One? How Much? What Biomarkers?

Fabian CJ, Kimler BF.

Cancer Prev Res (Phila). 2018 Apr;11(4):187-190. doi: 10.1158/1940-6207.CAPR-18-0061. Epub 2018 Mar 20.

12.

Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis.

Kumar D, Yalamanchali S, New J, Parsel S, New N, Holcomb A, Gunewardena S, Tawfik O, Lominska C, Kimler BF, Anant S, Kakarala K, Tsue T, Shnayder Y, Sykes K, Padhye S, Thomas SM.

Radiat Res. 2018 Mar;189(3):326-336. doi: 10.1667/RR14926.1. Epub 2018 Jan 19.

13.

Ovarian tissue cryopreservation in young females through the Oncofertility Consortium's National Physicians Cooperative.

Armstrong AG, Kimler BF, Smith BM, Woodruff TK, Pavone ME, Duncan FE.

Future Oncol. 2018 Feb;14(4):363-378. doi: 10.2217/fon-2017-0410. Epub 2018 Jan 18.

14.

Keep your eye on the target<sup/>.

Kimler BF.

Int J Radiat Biol. 2018 Aug;94(8):756-758. doi: 10.1080/09553002.2017.1393580. Epub 2017 Nov 6.

PMID:
29035121
15.

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.

Klemp JR, Myers JS, Fabian CJ, Kimler BF, Khan QJ, Sereika SM, Stanton AL.

Support Care Cancer. 2018 Feb;26(2):575-583. doi: 10.1007/s00520-017-3869-3. Epub 2017 Aug 28.

16.

PD-L1 in breast cancer: comparative analysis of 3 different antibodies.

Karnik T, Kimler BF, Fan F, Tawfik O.

Hum Pathol. 2018 Feb;72:28-34. doi: 10.1016/j.humpath.2017.08.010. Epub 2017 Aug 31.

PMID:
28843709
17.

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.

Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJ.

Breast Cancer Res Treat. 2017 Nov;166(2):491-500. doi: 10.1007/s10549-017-4429-8. Epub 2017 Aug 2.

PMID:
28770449
18.

An empirically derived dietary pattern associated with breast cancer risk is validated in a nested case-control cohort from a randomized primary prevention trial.

Hidaka BH, Kimler BF, Fabian CJ, Carlson SE.

Clin Nutr ESPEN. 2017 Feb;17:8-17. doi: 10.1016/j.clnesp.2016.10.008. Epub 2016 Nov 23.

PMID:
28361752
19.

Dietary Associations with a Breast Cancer Risk Biomarker Depend on Menopause Status.

Hidaka BH, Carlson SE, Kimler BF, Fabian CJ.

Nutr Cancer. 2016 Oct;68(7):1115-22. doi: 10.1080/01635581.2016.1208255. Epub 2016 Aug 11.

PMID:
27618149
20.

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.

Sharma P, López-Tarruella S, García-Saenz JA, Ward C, Connor CS, Gómez HL, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell AC, Del Monte-Millán M, Gonzalez-Rivera M, Massarrah T, Pelaez-Lorenzo B, Palomero MI, González Del Val R, Cortes J, Fuentes Rivera H, Bretel Morales D, Márquez-Rodas I, Perou CM, Wagner JL, Mammen JM, McGinness MK, Klemp JR, Amin AL, Fabian CJ, Heldstab J, Godwin AK, Jensen RA, Kimler BF, Khan QJ, Martin M.

Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.

21.

Combating radiation therapy-induced damage to the ovarian environment.

Duncan FE, Kimler BF, Briley SM.

Future Oncol. 2016 Jul;12(14):1687-90. doi: 10.2217/fon-2016-0121. Epub 2016 Apr 27. Review. No abstract available.

22.

Comparison of margin status and lesional size between radioactive seed localized vs conventional wire localized breast lumpectomy specimens.

Rarick J, Kimler BF, Tawfik O.

Ann Diagn Pathol. 2016 Apr;21:47-52. doi: 10.1016/j.anndiagpath.2016.01.003. Epub 2016 Mar 2.

PMID:
27040931
23.

Incorporating Biomarkers in Studies of Chemoprevention.

Fabian CJ, Kimler BF.

Adv Exp Med Biol. 2016;882:69-94. doi: 10.1007/978-3-319-22909-6_3. Review.

PMID:
26987531
24.

WINGLESS (WNT) signaling is a progesterone target for rat uterine stromal cell proliferation.

Rider V, Talbott A, Bhusri A, Krumsick Z, Foster S, Wormington J, Kimler BF.

J Endocrinol. 2016 May;229(2):197-207. doi: 10.1530/JOE-15-0523. Epub 2016 Mar 14.

25.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):912-21. doi: 10.1158/1940-6207.CAPR-14-0335.

26.

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Fabian CJ, Kimler BF, Zalles CM, Phillips TA, Metheny T, Petroff BK, Havighurst TC, Kim K, Bailey HH, Heckman-Stoddard BM.

Cancer Prev Res (Phila). 2015 Dec;8(12):1146-55. doi: 10.1158/1940-6207.CAPR-15-0109. Epub 2015 Sep 21.

27.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):922-31. doi: 10.1158/1940-6207.CAPR-14-0336. Epub 2015 Aug 14.

28.

Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.

Ford NA, Rossi EL, Barnett K, Yang P, Bowers LW, Hidaka BH, Kimler BF, Carlson SE, Shureiqi I, deGraffenried LA, Fabian CJ, Hursting SD.

Cancer Prev Res (Phila). 2015 Sep;8(9):796-806. doi: 10.1158/1940-6207.CAPR-15-0018. Epub 2015 Jun 22.

29.

Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development.

Delman DM, Fabian CJ, Kimler BF, Yeh H, Petroff BK.

Nutr Cancer. 2015;67(5):857-64. doi: 10.1080/01635581.2015.1042549. Epub 2015 May 26.

30.

Omega-3 fatty acids for breast cancer prevention and survivorship.

Fabian CJ, Kimler BF, Hursting SD.

Breast Cancer Res. 2015 May 4;17:62. doi: 10.1186/s13058-015-0571-6. Review.

31.

Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.

Rao D, Kimler BF, Nothnick WB, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2015 Jun;46(6):876-83. doi: 10.1016/j.humpath.2015.02.015. Epub 2015 Mar 10.

32.

Omega-3 and omega-6 Fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology.

Hidaka BH, Li S, Harvey KE, Carlson SE, Sullivan DK, Kimler BF, Zalles CM, Fabian CJ.

Cancer Prev Res (Phila). 2015 May;8(5):359-64. doi: 10.1158/1940-6207.CAPR-14-0351. Epub 2015 Feb 23.

33.

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer.

Connor CS, Kimler BF, Mammen JM, McGinness MK, Wagner JL, Alsop SM, Ward C, Fabian CJ, Khan QJ, Sharma P.

J Surg Oncol. 2015 Feb;111(2):198-202. doi: 10.1002/jso.23790. Epub 2014 Sep 29.

PMID:
25266871
34.

The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer.

Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA.

J Cancer Ther Res. 2014 Mar 19;3(2):1-11. doi: 10.7243/2049-7962-3-2.

35.

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK.

Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.

36.

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, Phillips TA, Metheny T, Aversman S, Yeh HW, Zalles CM, Mills GB, Hursting SD.

Breast Cancer Res Treat. 2013 Nov;142(1):119-32. doi: 10.1007/s10549-013-2730-8. Epub 2013 Oct 19.

37.

Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.

Aljitawi OS, Xiao Y, Eskew JD, Parelkar NK, Swink M, Radel J, Lin TL, Kimler BF, Mahnken JD, McGuirk JP, Broxmeyer HE, Vielhauer G.

Blood Cells Mol Dis. 2014 Jan;52(1):59-67. doi: 10.1016/j.bcmd.2013.07.013. Epub 2013 Aug 14.

38.

Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention.

Fabian CJ, Kimler BF.

Am Soc Clin Oncol Educ Book. 2013:97-101. doi: 10.1200/EdBook_AM.2013.33.97.

39.

Assessment of RNA in human breast tissue sampled by random periareolar fine needle aspiration and ductal lavage and processed as fixed or frozen specimens.

Phillips TA, Fabian CJ, Kimler BF, Petroff BK.

Reprod Biol. 2013 Mar;13(1):75-81. doi: 10.1016/j.repbio.2013.01.179. Epub 2013 Feb 19.

PMID:
23522074
40.

Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant.

Tawfik K, Kimler BF, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2013 Jan;44(1):39-46. doi: 10.1016/j.humpath.2012.05.007. Epub 2012 Aug 30.

PMID:
22939959
41.

Grading ductal carcinoma in situ of the breast using an automated proliferation index.

Stasik CJ, Davis M, Kimler BF, Fan F, Damjanov I, Thomas P, Tawfik OW.

Ann Clin Lab Sci. 2011 Spring;41(2):122-30.

PMID:
21844569
42.

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.

Tawfik K, Kimler BF, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2012 Jan;43(1):23-30. doi: 10.1016/j.humpath.2011.04.011. Epub 2011 Jul 20.

PMID:
21777944
43.

Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.

Tawfik O, Davis K, Kimler BF, Davis MK, Hull S, Fan F, Khan QJ, O'Dea AP, Thomas P.

Ann Clin Lab Sci. 2010 Fall;40(4):315-23.

PMID:
20947804
44.

Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes.

Kubicek GJ, Kimler BF, Wang F, Reddy EK, Girod DA, Williamson SK.

Am J Clin Oncol. 2011 Aug;34(4):380-4. doi: 10.1097/COC.0b013e3181e9c0a2.

PMID:
20881477
45.

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA.

Cancer Prev Res (Phila). 2010 Oct;3(10):1342-50. doi: 10.1158/1940-6207.CAPR-10-0022. Epub 2010 Aug 19.

46.

The relationship between vitamin D and breast cancer incidence and natural history.

Khan QJ, Kimler BF, Fabian CJ.

Curr Oncol Rep. 2010 Mar;12(2):136-42. doi: 10.1007/s11912-010-0081-8. Review.

PMID:
20425599
47.

Estradiol targets T cell signaling pathways in human systemic lupus.

Walters E, Rider V, Abdou NI, Greenwell C, Svojanovsky S, Smith P, Kimler BF.

Clin Immunol. 2009 Dec;133(3):428-36. doi: 10.1016/j.clim.2009.09.002. Epub 2009 Sep 30.

48.

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.

Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, Klemp JR, Fabian CJ.

Breast Cancer Res Treat. 2010 Jan;119(1):111-8. doi: 10.1007/s10549-009-0495-x. Epub 2009 Aug 5.

49.

Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes.

Park CH, Kimler BF, Yi SY, Park SH, Kim K, Jung CW, Kim SH, Lee ER, Rha M, Kim S, Park MH, Lee SJ, Park HK, Lee MH, Yoon SS, Min YH, Kim BS, Kim JA, Kim WS.

Eur J Haematol. 2009 Aug;83(2):108-18. doi: 10.1111/j.1600-0609.2009.01252.x. Epub 2009 Mar 5.

PMID:
19284416
50.

A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.

Stevens E, Kimler BF, Davis MK, Fan F, Thomas P, Wang XY, Damjanov I, Tawfik OW.

Ann Clin Lab Sci. 2009 Winter;39(1):25-31.

PMID:
19201737

Supplemental Content

Loading ...
Support Center